Search

everythinglearnresearchcommunity

for

Search:↓

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

Graft-versus-host disease is a complication where donor immune cells attack the recipient's body, often affecting the skin, liver, and gastrointestinal tract.

A woman's sudden hair loss three years after a bone marrow transplant was a sign of chronic graft-versus-host disease but improved with treatment.

Adjusting the medication tacrolimus resolved a boy's red nail beds after a stem cell transplant.

Permanent hair loss after bone marrow transplant can be caused by chemotherapy or chronic graft-versus-host disease.

Some children who had stem cell transplants developed permanent hair loss, especially when treated with a drug called busulphan.

A man developed autoimmune issues after a transplant, improved with treatment, but died from leukemia relapse.

A Japanese bone marrow transplant patient developed a rare skin cancer possibly linked to long-term use of the medication voriconazole.

Chronic graft-versus-host disease in the skin shows strong Th1 immune response and unique barrier issues.

People with allergies or high eosinophil levels have a higher chance of severe hair loss from alopecia areata, and sudden hair loss can indicate chronic graft-versus-host disease.

A five-month-old boy with Omenn syndrome successfully recovered after a stem cell transplant with reduced intensity conditioning.

ATIR101 improves survival in stem cell transplant patients; Australian stem cell treatment decisions are influenced by regulation changes.

A 65-year-old man developed a serious skin cancer linked to a drug he was taking for a fungal infection after a bone marrow transplant.

Graft-versus-host disease occurs when donor immune cells attack the recipient's body, causing skin, gut, and liver damage.

Patients with chronic graft-versus-host disease often have skin problems like vitiligo and alopecia areata.

Skin issues from chronic graft-versus-host disease greatly affect daily life, needing teamwork between blood and skin doctors.

A man got six skin cancers within a year after a cell transplant for leukemia but was cancer-free 32 months later; skin checks are important post-transplant.

cGVHD often severely affects the skin, causing rapid aging and other issues.

Ruxolitinib may help treat hair loss and symptoms in patients with chronic graft-versus-host disease.

Donor lymphocyte infusions effectively treated leukemia relapse but caused vitiligo and alopecia areata.

Skin changes like hair loss, white patches, and nail changes are common in children after bone marrow transplants, often linked to chronic rejection.

Older age is the main risk factor for hemorrhagic cystitis after stem cell transplants.

Skin problems are common after stem cell transplants, and early treatment by dermatologists can improve patient outcomes.

The patient's long-term hair loss was caused by leukemia treatments and low estrogen levels, worsened by her genetic tendency for hair loss.

EMT plays a key role in skin fibrosis and offers new therapy targets.

The document concludes that accurate diagnosis of different types of hair loss requires careful examination of hair and scalp tissue, considering both clinical and microscopic features.

Mesenchymal stem cells may effectively treat and prevent allergic skin conditions.

Two teenage brothers had a rare, treatment-resistant form of female-pattern hair loss with unusual scalp changes.

EpiLife® media and younger donor age improve artificial skin model quality.

CD8+ T cells play a key role in graft-versus-host disease in certain mice models.